T-cell acute lymphoblastic leukemia
Conditions
Interventions
Sponsors
Department of hematology, Xinqiao hospital, Army Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The patients with T-cell acute lymphoblastic leukemia undergone allogeneic hematopoietic stem cell transplantation after inducion therapy and 2-cycle intensive treatment with high dose methotrexate; 2. The hematopoietic reconstitution is stable at day 30 to 45 after allogeneic hematopoietic stem cell transplantation and the acute lymphoblastic leukemia is complete remission; 3. The patients age 14 to 55 year old, and the KPS is over 60. The estimated survival is over three months; 4. The important organs are function,such as heart and brain.
Exclusion criteria
Exclusion criteria: 1. serious systemic organ dysfunction; 2. Patient with malignant tumor that needs to be treat; 3. The patients with clinical symptom of brain dysfunction or serious psychiosis that can't understand or obey the study; 4. Patients that can't followed up as scheduled.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year disease-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| 1-year oversurvival;1-year relapse rate; | — |
Countries
China
Contacts
Public ContactZhang Cheng
Department of hematology, Xinqiao hospital, Army Medical University
Outcome results
None listed